AmpliPhi Biosciences (TGEN) Announces UK Grant Award to Develop its Novel Antimicrobial Technology
4/12/2011 9:18:43 AM
SEATTLE & LONDON--(BUSINESS WIRE)--AmpliPhi Biosciences Corporation (Pink Sheets:APHB) is pleased to announce that its wholly owned subsidiary, Biocontrol Ltd., has been awarded UK Government Funding through the Technology Strategy Board for research and development using genomics-based technologies. As part of the £4.5 million (U.S. $7.3 million), eleven project initiative, this specific project will fund a consortium of five industrial and academic partners led by Unilever PLC (NYSE: UL). During the three year program of research, AmpliPhi Biosciences will exploit novel genomic information to develop next generation, specific, natural antimicrobials for use in the personal care industry.
comments powered by